Digital Health for Patellofemoral Pain

NCT07544940 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-22

No results posted yet for this study

Summary

This randomized controlled superiority trial will compare a 6-week digital health rehabilitation program with a 6-week self-guided exercise program in adults with patellofemoral pain. Assessments will be performed at baseline, 6 weeks, and 18 weeks. The primary outcome will be change in AKPS from baseline to 6 weeks. Secondary outcomes will include pain intensity, self-reported function, psychological outcomes, quality of life, muscle strength, adherence, and adverse events.

Conditions

  • PFPS

Interventions

BEHAVIORAL

Digital health

Participants will receive a 6-week digital health program delivered through a smartphone application mini-program. The intervention will include: * PFP education (condition information, pain management, load management, and activity advice) * Progressive exercise advancement according to pain response and performance * Video demonstration and structured session guidance * Symptom tracking and exercise logging * Automated reminders and adherence support * Remote therapist feedback when required

BEHAVIORAL

Self-guided exercise

Participants will receive a 6-week self-guided home exercise program with initial instruction delivered in printed format. Participants will be advised to perform the exercises independently at home. No ongoing digital supervision, tailored feedback, or structured adherence prompts will be provided.

Sponsors & Collaborators

  • Chengdu Sport University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2026-12-15
Completion
2027-05-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07544940 on ClinicalTrials.gov